Intelligent Bio updates share count to 3.32M
INTELLIGENT BIO SOLUTIONS INC. updates investors on warrant exercises and share issuances, bringing total common shares outstanding to 3,316,803 as of September 10, 2026.
Rhea-AI Filing Summary
INTELLIGENT BIO SOLUTIONS INC. (INBS) reports an update to its capital structure. The company states that previously disclosed prefunded warrants were exercised for 285,000 shares of common stock, and 4,333 shares of restricted common stock were issued under an Investor Relations and Corporate Development Advisory Agreement. Following these issuances, the company reports that total outstanding common shares were 3,316,803 as of the close of business on September 10, 2026.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Shares from prefunded warrant exercises: 285,000 shares
Restricted common stock issued: 4,333 shares
Total common shares outstanding: 3,316,803 shares
+2 more
5 metrics
Shares from prefunded warrant exercises
285,000 shares
Exercise of previously disclosed prefunded warrants to purchase common stock
Restricted common stock issued
4,333 shares
Issued under Investor Relations and Corporate Development Advisory Agreement dated February 29, 2024
Total common shares outstanding
3,316,803 shares
As of close of business on September 10, 2026
Par value of common stock
$0.01 per share
Title of each class listed on The Nasdaq Stock Market LLC
Advisory agreement date
February 29, 2024
Date of Investor Relations and Corporate Development Advisory Agreement under which restricted shares were issued
Key Terms
prefunded warrants, restricted common stock, Investor Relations and Corporate Development Advisory Agreement, emerging growth company
4 terms
prefunded warrants financial
"As a result of (a) the exercise of previously disclosed outstanding prefunded warrants"
Prefunded warrants are a security that gives the holder the right to convert the warrant into a share after paying a very small remaining amount because almost the full purchase price was paid upfront. They matter to investors because exercising them increases the company’s outstanding shares (dilution) and can provide immediate cash to the issuer while allowing holders to bypass ownership limits or simplify timing, similar to buying a nearly-complete gift card that only needs a tiny top-up to use.
restricted common stock financial
"and (b) the issuance of 4,333 shares of restricted common stock"
Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.
Investor Relations and Corporate Development Advisory Agreement financial
"pursuant to the previously disclosed Investor Relations and Corporate Development Advisory Agreement"
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.
